Novel ketone body therapy for managing Alzheimer's disease: An Editorial Highlight for Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease

Michelle A Puchowicz; Thomas N Seyfried

doi:10.1111/jnc.13979

Novel ketone body therapy for managing Alzheimer's disease: An Editorial Highlight for Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease

J Neurochem. 2017 Apr;141(2):162-164. doi: 10.1111/jnc.13979. Epub 2017 Mar 15.

Authors

Michelle A Puchowicz¹, Thomas N Seyfried²

Affiliations

¹ Department of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
² Department of Biology, Boston College, Chestnut Hill, Massachusetts, USA.

PMID: 28299805
DOI: 10.1111/jnc.13979

Abstract

Read the highlighted article 'Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease' on page 195.

Publication types

Editorial
Comment

MeSH terms

Alzheimer Disease*
Amino Acids
Animals
Citric Acid Cycle*
Hippocampus
Humans
Mice
Mice, Transgenic

Substances

Amino Acids